Human Abuse Liability Assessment of Tobacco and Nicotine Products: Approaches for Meeting Current Regulatory Recommendations

被引:11
|
作者
Vansickel, Andrea [1 ]
Baxter, Sarah [2 ]
Sherwood, Neil
Kong, Michael [3 ]
Campbell, Leanne [2 ]
机构
[1] Altria Client Serv LLC, Regulatory Affairs, Richmond, VA 23225 USA
[2] RAI Serv Co, Clin Studies, Winston Salem, NC USA
[3] Altasci Clin Res, Montreal, PQ, Canada
关键词
REDUCED EXPOSURE PRODUCTS; ELECTRONIC CIGARETTE; COMBUSTIBLE CIGARETTES; REINFORCING EFFICACY; INTRAVENOUS NICOTINE; DELIVERY; PHARMACOKINETICS; DISCRIMINATION; SMOKERS; VALIDATION;
D O I
10.1093/ntr/ntab183
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Many regulatory bodies now recommend that tobacco product manufacturers provide information regarding new tobacco products' abuse liability to inform regulatory authorization of currently marketed tobacco products or new product applications (including premarket tobacco product applications in the United States). In addition, the US Food and Drug Administration (FDA) recommends including this information as part of modified risk tobacco product applications. Regulators, including FDA, and many public health officials and researchers consider abuse liability assessment a model which predicts the likelihood that the use of the tobacco product would result in addiction and be used repeatedly or even sporadically resulting in undesirable effects. Abuse liability of a new, potentially reduced harm product can also inform its ability to substitute completely for more harmful tobacco products. While many methods exist, no standard tobacco product abuse liability assessment has been established. The purpose of this review is to provide background information and practical recommendations for human abuse liability testing methods to meet tobacco regulatory needs. A combination of nicotine test product pharmacokinetic, subjective effect and/or behavioral response, and physiological response data relative to comparator products with known abuse liability satisfies some regulatory requirements. Implications: This review provides a practical inspection of the current, international regulatory recommendations for abuse liability assessment of tobacco and regulatory review of such information within the United States and also recommends study designs and methods for abuse liability testing of tobacco products based on scientific and regulatory knowledge. Given that tobacco product abuse liability testing is of increasing interest to regulatory bodies globally, especially with the emergence of novel tobacco products, this timely work provides background and functional recommendations for tobacco product abuse liability testing.
引用
收藏
页码:295 / 305
页数:11
相关论文
共 50 条
  • [31] Assessment of the Exposure to Aromatic Amines in Users of Various Tobacco/Nicotine Products
    Scherer, Gerhard
    Riedel, Kirsten
    Pluym, Nikola
    Scherer, Max
    ACS OMEGA, 2022, 7 (45): : 41775 - 41782
  • [32] Endocrine Disruption: Current approaches for regulatory testing and assessment of plant protection products are fit for purpose
    Day, Peter
    Green, Richard M.
    Gross, Melanie
    Weltje, Lennart
    Wheeler, James R.
    TOXICOLOGY LETTERS, 2018, 296 : 10 - 22
  • [33] Differential Effects of Nicotine Delivery Rate on Abuse Potential and Urges to Smoke: A Human Laboratory Study With Implications for Tobacco Regulatory Science
    De Aquino, Joao
    Gueorguieva, Ralitza
    Eid, Tore
    Sofuoglu, Mehmet
    NEUROPSYCHOPHARMACOLOGY, 2021, 46 (SUPPL 1) : 427 - 428
  • [34] HUMAN DRUG-ABUSE LIABILITY ASSESSMENT - OPIOIDS AND ANALGESICS
    BIGELOW, GE
    BRITISH JOURNAL OF ADDICTION, 1991, 86 (12): : 1615 - 1628
  • [35] Key challenges for in vitro testing of tobacco products for regulatory applications: Recommendations for dosimetry
    Miller-Holt, Jacqueline
    Behrsing, Holger
    Crooks, Ian
    Curren, Rodger
    Demir, Kubilay
    Gafner, Jeremie
    Gillman, Gene
    Hollings, Michael
    Leverette, Robert
    Oldham, Michael
    Simms, Liam
    Stankowski, Leon F.
    Thorne, David
    Wieczorek, Roman
    Moore, Martha M.
    DRUG TESTING AND ANALYSIS, 2023, 15 (10) : 1175 - 1188
  • [36] Animal models to assess the abuse liability of tobacco products: Effects of smokeless tobacco extracts on intracranial self-stimulation
    Harris, Andrew C.
    Tally, Laura
    Schmidt, Clare E.
    Muelken, Peter
    Stepanov, Irina
    Saha, Subhrakanti
    Vogel, Rachel Isaksson
    LeSage, Mark G.
    DRUG AND ALCOHOL DEPENDENCE, 2015, 147 : 60 - 67
  • [37] Common Measures to Evaluate Flavored Tobacco Products: Recommendations From the Tobacco Centers for Regulatory Science (TCORS) Flavored Tobacco Products Measurement Subcommittee
    Bansal-Travers, Maansi
    Price, Simani M.
    Bold, Krysten W.
    Villanti, Andrea C.
    Barnes, Andrew
    Chansky, Melanie
    Krishnan-Sarin, Suchitra
    Goniewicz, Maciej L.
    NICOTINE & TOBACCO RESEARCH, 2023, 25 (01) : 159 - 163
  • [38] New tobacco and nicotine products in Latin America and the Caribbean: assessing the market and regulatory environment
    Crosbie, Eric
    Severini, Gianella
    Beem, Alexandra
    Tran, Brian
    Sebrie, Ernesto Marcelo
    TOBACCO CONTROL, 2023, 32 (04) : 458 - 466
  • [39] Sugars and Sweeteners in Tobacco and Nicotine Products: Food and Drug Administration's Regulatory Implications
    Rezk-Hanna, Mary
    Talhout, Reinskje
    Jordt, Sven-Eric
    NICOTINE & TOBACCO RESEARCH, 2023, 25 (04) : 838 - 840
  • [40] Assessment of the Exposure to Tobacco-Specific Nitrosamines and Minor Tobacco Alkaloids in Users of Various Tobacco/Nicotine Products
    Scherer, Gerhard
    Scherer, Max
    Muetze, Janina
    Hauke, Tobias
    Pluym, Nikola
    CHEMICAL RESEARCH IN TOXICOLOGY, 2022, 35 (04) : 684 - 693